Why Staging Matters
Staging is the process of determining how much cancer is in the body and where it is located. Staging guides treatment decisions, helps predict prognosis, and allows doctors and researchers to compare outcomes across patients.
The TNM System
Most solid tumors are staged using the TNM system, developed by the American Joint Committee on Cancer (AJCC):
- T (Tumor): Size and extent of the primary tumor. T0 = no tumor; T1-T4 = increasing size/involvement
- N (Nodes): Whether cancer has spread to nearby lymph nodes. N0 = no lymph node involvement; N1-N3 = increasing lymph node involvement
- M (Metastasis): Whether cancer has spread to distant organs. M0 = no distant spread; M1 = distant metastasis present
Stage Groups
TNM values are combined into overall stage groups:
- Stage I: Small tumor, no lymph node involvement, no spread. Usually the most treatable stage.
- Stage II: Larger tumor and/or limited lymph node involvement. Often still curable.
- Stage III: Locally advanced — larger tumor, more lymph node involvement, but no distant spread. Treatment is more intensive.
- Stage IV: Metastatic — cancer has spread to distant organs. Treatment focuses on control and quality of life; cure is less common but possible for some cancer types.
Stage Is Not Destiny
Staging provides important information, but many other factors affect prognosis and treatment response — including molecular subtype, biomarkers, overall health, and available treatments. Stage IV cancer is not always a death sentence: some patients with metastatic cancer live for many years with effective treatment.